Ferrous Gluconate Encyclopedia — Scientific Background

What Is Ferrous Gluconate?

Ferrous gluconate (CAS 299-29-6 for anhydrous; CAS 6047-12-7 for dihydrate), also known as iron(II) gluconate or iron(2+) di-D-gluconate dihydrate, is the ferrous salt of D-gluconic acid. It is chemically characterized by the molecular formula C₁₂H₂₂FeO₁₄ (anhydrous) and C₁₂H₂₂FeO₁₄·2H₂O (dihydrate), with molecular weights of 446.15 g/mol and 482.17 g/mol, respectively. The compound is typically a grayish-green or yellowish powder or granules with a caramel-like odor. It is soluble in water (1 g in about 10 mL) and practically insoluble in alcohol. Ferrous gluconate contains approximately 11.6%–12% elemental iron by weight.

Regulatory Status and Pharmacopoeial Standards

Ferrous gluconate holds a well-established regulatory position as both a pharmaceutical and food ingredient:

FDA Status — Ferrous gluconate is listed in the FDA's Substances Added to Food database (formerly EAFUS) with CAS Registry No. 6047-12-7 and UNII: U1B11I423Z. The FDA has affirmed ferrous gluconate as a nutrient supplement and color additive for use in food.

USP Monograph — Ferrous Gluconate contains not less than 97.0% and not more than 102.0% of C₁₂H₂₂FeO₁₄, calculated on the dried basis. The USP monograph specifies identification tests, loss on drying (6.5%–10.0% when dried at 105°C for 16 hours), chloride limits (0.07%), oxalic acid limits, sulfate limits (0.1%), arsenic limits (3 ppm), and limit of ferric iron.

Food Additive — Ferrous gluconate functions as a nutrient supplement, color additive, and stabilizer with the E number E579. It is permitted in food in the European Union, United States, Japan, and Korea to control acidity in foods.

Physiological Functions of Iron

Iron is an essential trace mineral required for numerous physiological processes:

• Hemoglobin Synthesis — Iron is the central atom in the heme group of hemoglobin, enabling oxygen transport from the lungs to tissues

• Oxygen Transport — Iron-containing myoglobin facilitates oxygen storage and transport in muscle tissue

• Electron Transfer — Iron-sulfur clusters and heme groups participate in mitochondrial electron transport chain reactions

• Enzymatic Reactions — Iron is a cofactor for numerous enzymes involved in DNA synthesis, neurotransmitter production, and immune function

• Energy Metabolism — Iron-containing cytochromes are essential for ATP production

• Cognitive Function — Iron contributes to normal cognitive function in the development of children

Mechanisms of Action and Absorption

Conventional Iron Absorption Pathway

Iron absorption from ferrous gluconate follows the normal physiological pathway for non-heme iron. Ferrous iron (Fe²⁺) is absorbed primarily in the duodenum and proximal jejunum through the divalent metal transporter 1 (DMT1). Once inside the enterocyte, iron is either stored as ferritin or transported across the basolateral membrane by ferroportin into the bloodstream, where it binds to transferrin for distribution to tissues. The gluconate anion provides greater stability to iron by preventing its decomposition inside the intestinal tube, causing much less gastric irritation than other commonly used inorganic ferrous salts, such as ferrous sulfate.

liposomal Absorption Pathway

Liposomal encapsulation provides a fundamentally different absorption mechanism. The liposomal phospholipid bilayer is similar to cell membranes in the human body, which makes them progressively biocompatible. Liposomal iron has emerged as a promising formulation with improved tolerance and enhanced bioavailability, bypassing the hepcidin–ferroportin blockade. The liposomal delivery system bypasses the regulated DMT1 absorption pathway and provides an alternative route of cellular entry.

The Bioavailability Challenge

Despite iron's essential physiological functions, conventional oral iron presents absorption limitations. Iron absorption relies on tightly regulated intestinal transport systems, and increasing the administered dose does not proportionally enhance absorption efficiency. Additionally, iron can bind with dietary inhibitors such as phytates and polyphenols, which reduce absorption. Conventional oral iron is limited by poor absorption, poor adherence and high hepcidin levels.

Liposomal encapsulation addresses these limitations through a phospholipid bilayer that protects iron from gastric degradation and dietary inhibitors, and enhances intestinal absorption through lipid-mediated pathways. Liposomal iron has enhanced iron bioavailability and can reduce gastrointestinal side effects and improve compliance.

Liposomal ferrous gluconate

Liposomal encapsulation of ferrous gluconate provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the iron-gluconate complex, forming a protective shell that enhances absorption and reduces gastrointestinal irritation. This delivery system:

• Protects ferrous iron from oxidation to the less absorbable ferric form

• Enhances intestinal absorption through lipid-mediated pathways

• Provides targeted delivery to iron-requiring tissues

• Reduces gastrointestinal side effects by minimizing direct mucosal contact

• Bypasses the hepcidin–ferroportin blockade

Clinical Evidence

Pediatric Chronic Kidney Disease Anemia

A single-center, open-label, randomized controlled trial evaluated 68 CKD stage 3–5 participants aged ≤14 years not on hemodialysis. Participants were randomized into conventional oral iron (Group 1) or liposomal iron (Group 2) and assessed at enrolment and after 12 weeks for hemoglobin and iron profile. After 12 weeks, hemoglobin increased by 1.2 g/dL in Group 2 versus 0.6 g/dL in Group 1, though not statistically significant (p=0.28). Serum iron significantly increased in Group 2 (55.7±18.2 to 70.7±19.9 mcg/dL, p=0.03). Transferrin saturation improved significantly in Group 2 (22.6±15.6% to 30.2±12.6%, p=0.05). Adverse event incidence was lower in Group 2 (19.4%) compared to Group 1 (43.7%). The study concluded that liposomal iron is not better than conventional iron in improving hemoglobin level, but serum iron and TSAT improved significantly with liposomal iron accompanied by fewer adverse events.

Liposomal Iron in Anemic Children with CKD

A separate study evaluating liposomal SunActive versus conventional iron for treatment of iron-deficiency anemia in children aged 2–12 years demonstrated that liposomal iron, a novel oral formulation of ferric pyrophosphate, demonstrates improved gastrointestinal absorption and bioavailability with fewer side effects than conventional iron.

Preoperative Iron Supplementation

A comparative study of ferric carboxymaltose and liposomal iron (SiderAL Forte) in optimizing preoperative iron levels and preventing postoperative anemia in patients undergoing 360-degree lipoadminoplasty is ongoing. Although oral iron supplementation is a common approach, its limited bioavailability and gastrointestinal intolerance often hinder effective anemia management.

Safety and Regulatory

Ferrous gluconate is generally well tolerated, with fewer gastrointestinal side effects compared to some other iron compounds. The most common side effects are gastrointestinal, including nausea, abdominal pain, diarrhea, and constipation. High doses in some people may have an effect on the lining of the stomach or gut, which may become narrower or perforated. Continuous use may cause constipation and faecal impaction.

Liposomal encapsulation helps reduce these side effects through improved absorption and reduced gastrointestinal mucosal contact. Iron status should be monitored through hemoglobin, ferritin, and transferrin saturation to guide dosing, as even well-tolerated forms should not be supplemented without confirmed deficiency due to the risks of iron overload.

Ferrous gluconate is widely commercialized as a dietary supplement ingredient, pharmaceutical agent, and food additive. It is monographed in the USP, European Pharmacopoeia, and Food Chemicals Codex. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

59$/KG